Anrikefon presents a peptide-derived scaffold with balanced hydrophobic and polar residues that govern its structural adaptability. The sequence offers a platform for studying binding determinants and charge distribution. Researchers examine its conformational dynamics across solvent environments. Uses include ligand-model development, peptide-design research, and biophysical interaction analysis.
CAT No: R2624
CAS No:2269511-95-5
Synonyms/Alias:Anrikefon;Anrikefon [INN];22SCY98BXV;2269511-95-5;UNII-22SCY98BXV;1-(7-(D-Phenylalanyl-D-phenylalanyl-D-leucyl-D-lysyl)-2,7-diazaspiro(3.5)non-2-yl)ethanone;1-(7-(D-Phenylalanyl-D-phenylalanyl-D-leucyl-D-lysyl)- 2,7-diazaspiro(3.5)nonan-2-yl)ethan-1-one;Ethanone, 1-(7-(D-phenylalanyl-D-phenylalanyl-D-leucyl-D-lysyl)-2,7-diazaspiro(3.5)non-2-yl)-;1-[7-(D-phenylalanyl-D-phenylalanyl-D-leucyl-D-lysyl)- 2,7-diazaspiro[3.5]nonan-2-yl]ethan-1-one;1-[7-(D-Phenylalanyl-D-phenylalanyl-D-leucyl-D-lysyl)-2,7-diazaspiro[3.5]non-2-yl]ethanone;Ethanone, 1-[7-(D-phenylalanyl-D-phenylalanyl-D-leucyl-D-lysyl)-2,7-diazaspiro[3.5]non-2-yl]-;CHEMBL5095089;SCHEMBL20669227;GLXC-27229;HY-P3445;DA-70882;CS-0541917;(2R)-N-[(2R)-1-(2-acetyl-2,7-diazaspiro[3.5]nonan-7-yl)-6-amino-1-oxohexan-2-yl]-2-[[(2R)-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanamide;
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.